2021

• Yarmarkovich, M., Marshall, Q.F., Warrington, J.M. et al. Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs. (2021). (Nature)

​

2020

• Yarmarkovich M, Farrel A, Sison A, di Marco M, Raman P, Parris JL, et al. Immunogenicity and Immune Silence in Human Cancer. (2020) (Frontiers in Immunology)

• Yarmarkovich, M., Warrington, J.M., Farrel, A., and Maris, J.M. Identification of SARS-CoV-2 Vaccine Epitopes Predicted to Induce Long-term Population-Scale Immunity. (2020) (Cell Reports Medicine)

• Overall, S.A., Toor, J.S., Hao, S., Yarmarkovich, M., O’Rourke, S.M., Morozov, G.I., Nguyen, S., Japp, A.S., Gonzalez, N., and Moschidi, D. High throughput pMHC-I tetramer library production using chaperone-mediated peptide exchange. (2020) (Nature Communications)

​

2019

• Yarmarkovich M, Maris JM. When Cold Is Hot: Immune Checkpoint Inhibition Therapy for Rhabdoid Tumors. (2019) (Cancer Cell)

​

2018

• Toor JS, Rao AA, McShan AC, Yarmarkovich M, Nerli S, Yamaguchi K, et al. A Recurrent Mutation in Anaplastic Lymphoma Kinase with Distinct Neoepitope Conformations. (2018) (Frontiers in Immunology)

• Rajbhandari P, Lopez G, Capdevila C, Salvatori B, Yu J, Rodriguez-Barrueco R, et al. Cross-Cohort Analysis Identifies a TEAD4–MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma. (2018) (Cancer Discovery)

​

2016

• Yang J, Hotz T, Broadnax L, Yarmarkovich M, Elbaz-Younes I, Hirschi KD. Anomalous uptake and circulatory characteristics of the plant-based small RNA MIR2911. (2016) (Scientific Reports)

​

2015

• Yarmarkovich M, Hirschi KD. Digesting dietary miRNA therapeutics. (2015) (Oncotarget)

​

2014

• Zheng K, Yarmarkovich M, Bantog C, Bayer R, Patapoff TW. Influence of glycosylation pattern on the molecular properties of monoclonal antibodies. (2014) (mAbs)

​